News Conference News TCT 2025 DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES Yael L. Maxwell November 04, 2025
News Conference News TCT 2024 In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI Yael L. Maxwell October 29, 2024
News Conference News TCT 2023 In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS Yael L. Maxwell October 25, 2023
News Conference News TCT 2021 Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes Yael L. Maxwell November 09, 2021
News Conference News TCT 2021 Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets Caitlin E. Cox November 06, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Conference News TCT 2021 De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS Yael L. Maxwell October 22, 2021
News Conference News TCT 2020 Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk Caitlin E. Cox October 15, 2020
Presentation TCT 2020 TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI Presenter: Byeong-Keuk Kim October 14, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
News Conference News TCT 2020 No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH L.A. McKeown October 14, 2020
News Conference News TCT 2019 TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients Todd Neale October 03, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
Presentation TCT 2019 AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation Presenter: Amit Vora September 28, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019
News Conference News TCT 2018 More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses Michael O'Riordan September 24, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018